Skip to Main Content

Xylazine "tranq" is in Maryland. What you need to know to stay safe.

About Xylazine

Xylazine, which some may refer to as “tranq,” is being mixed with street drugs and a person may not even be aware.

Xylazine is not an opioid. It is a very strong sedative used in veterinary medicine. It is not approved for use in humans. (Opioids are a group of drugs that include heroin and prescription medications like oxycodone, hydrocodone, morphine, fentanyl, and methadone.)

Xylazine is being added to street drugs and is often found in combination with fentanyl (a powerful synthetic opioid). It has increasingly been detected in overdose deaths.

Xylazine may be added to street drugs, at least in part, to extend the effects of fentanyl. Not everyone who uses fentanyl is intentionally seeking out xylazine. In some cases, people are not aware that xylazine is in the drugs they are buying and using.

The main effect of xylazine is heavy sedation, so the person who has overdosed will likely be unresponsive. When xylazine is found in combination with fentanyl, the signs and symptoms can include blue/grayish skin and slowed breathing and heart rate. 

Naloxone

Naloxone (also known as Narcan) will not reverse a xylazine overdose. However, because xylazine is almost always found in combination with opioids, including fentanyl, naloxone should still be administered whenever an opioid-involved overdose is suspected.

Learn more about how to find and administer naloxone in Maryland at https://beforeitstoolate.maryland.gov/naloxone/.

Wound Care

Xylazine is associated with severe wounds that spread and worsen quickly. The wounds occur regardless of how people use: smoking, snorting, or injecting. People should seek urgent medical attention if they exhibit extreme pain, fever or chills, if the wound turns black, if there is a foul odor, or if they experience bone and/or tissue tenderness or damage.

People who use xylazine heavily and frequently are at risk of withdrawal. Xylazine withdrawal is often marked by irritability, anxiety and a feeling of unease. Maryland’s Good Samaritan Law (or “Good Sam”) protects those who assist with an emergency alcohol- or drug-related overdose.The Good Samaritan Law also protects the person experiencing the emergency medical overdose. Learn more.

Additional Resources

Xylazine in Maryland Report

To respond to the potential threat of xylazine, the Maryland Department of Health’s Overdose Data to Action team developed the Maryland Xylazine Workgroup to address questions, share data, and make recommendations for practice, surveillance, and policy development. Their report summarizes the efforts of the Workgroup and presents critical information about xylazine in Maryland.

Rapid Analysis of Drugs (RAD)

RAD is a statewide drug-checking program overseen by the Maryland Department of Health’s Center for Harm Reduction Services. RAD tests paraphernalia samples voluntarily submitted by participants of syringe services programs in Maryland and provides information on drug composition in near real-time.

doit-GOCIWP-w01
Close window
Close Disclaimer

Google Translate Disclaimer

The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology ​​​to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.